MSH3 (Redirect)

MSH3 (Redirect)

Overview

MSH3 (MutS homolog 3) is a DNA mismatch repair protein that plays a critical role in maintaining genomic stability. As a member of the MutS protein family, MSH3 forms heterodimeric complexes with other mismatch repair proteins to recognize and correct DNA replication errors. In recent years, MSH3 has gained significant attention in neurodegeneration research due to its association with trinucleotide repeat expansion diseases, particularly Huntington's disease and other polyglutamine disorders. The human MSH3 gene is located on chromosome 5q11.1 and encodes a protein of approximately 960 amino acids.

Function/Biology

MSH3 functions as a key component of the post-replicative mismatch repair (MMR) pathway, which corrects errors made during DNA replication. The protein forms a heterodimer with MSH2, creating the MutS-alpha complex (MSH2-MSH3) that recognizes insertion-deletion loops (IDLs) and small mismatches in DNA. This recognition triggers a cascade of events involving other mismatch repair proteins, including MLH1 and PMS2, ultimately leading to excision and resynthesis of the error-containing DNA strand.

MSH3 (Redirect)

Overview

MSH3 (MutS homolog 3) is a DNA mismatch repair protein that plays a critical role in maintaining genomic stability. As a member of the MutS protein family, MSH3 forms heterodimeric complexes with other mismatch repair proteins to recognize and correct DNA replication errors. In recent years, MSH3 has gained significant attention in Neurodegeneration research due to its association with trinucleotide repeat expansion diseases, particularly Huntington's disease and other polyglutamine disorders. The human MSH3 gene is located on chromosome 5q11.1 and encodes a protein of approximately 960 amino acids.

Function/Biology

MSH3 functions as a key component of the post-replicative mismatch repair (MMR) pathway, which corrects errors made during DNA replication. The protein forms a heterodimer with MSH2, creating the MutS-alpha complex (MSH2-MSH3) that recognizes insertion-deletion loops (IDLs) and small mismatches in DNA. This recognition triggers a cascade of events involving other mismatch repair proteins, including MLH1 and PMS2, ultimately leading to excision and resynthesis of the error-containing DNA strand.

MSH3 contains several functionally important domains: an N-terminal ATPase domain involved in nucleotide binding and hydrolysis, a DNA-binding domain that directly contacts mismatched DNA, and regions that facilitate protein-protein interactions with MSH2 and other MMR components. The protein's ability to hydrolyze ATP is essential for its translocation along DNA and for signaling downstream repair machinery. In addition to canonical mismatch repair, MSH3 participates in other DNA surveillance mechanisms, including the recognition of certain types of DNA damage and modulation of cell cycle checkpoints.

Role in Neurodegeneration

MSH3 has emerged as a critical factor in polyglutamine expansion diseases through its involvement in trinucleotide repeat stability. Huntington's disease, caused by CAG repeat expansions in the huntingtin gene, and other disorders like Spinocerebellar Ataxia types 1, 2, 3, and 6 are characterized by pathological expansion of repetitive DNA sequences. MSH3 dysfunction or reduced expression has been associated with increased repeat instability and expansions in transgenic disease models.

Recent genetic studies have identified MSH3 variants that influence the age of onset and progression rate in Huntington's disease patients. Loss-of-function MSH3 variants appear to promote larger repeat expansions during intergenerational transmission, while certain MSH3 polymorphisms correlate with accelerated disease progression. This suggests MSH3 plays a central role in modulating repeat expansion dynamics, which has profound implications for disease manifestation and severity.

Molecular Mechanisms

MSH3's involvement in trinucleotide repeat expansion occurs through several interconnected mechanisms. The repetitive DNA sequences form secondary structures (hairpins and slipped-strand mispairing intermediates) that are recognized by the MSH2-MSH3 complex. Paradoxically, both increased and decreased MSH3 activity can promote repeat expansions through distinct pathways: reduced MMR efficiency may allow expansion-prone structures to escape correction, while certain MMR processing events may actively destabilize repeats.

MSH3 also interacts with the MLH1-PMS2 endonuclease complex in a coordinated manner that can either facilitate repeat contraction or expansion depending on the cellular context and repeat structure. The protein's ATPase activity cycles between ATP-bound (active scanning) and ADP-bound (inactive) states, influencing its dwell time on repetitive sequences and ultimately affecting repeat stability. Additionally, MSH3 may be involved in transcription-associated repeat expansion, particularly in neurons where transcription through repetitive regions occurs preferentially.

Clinical/Research Significance

Understanding MSH3 function has opened new therapeutic avenues for polyglutamine diseases. MSH3-modulating compounds represent potential disease-modifying treatments that could slow or prevent repeat expansions. Genetic modulation of MSH3 expression in animal models has demonstrated feasibility for reducing repeat instability and improving phenotypic outcomes. Furthermore, MSH3 status may provide prognostic information for predicting disease severity in patients.

Related Entities

• MSH2 (MutS homolog 2) - MSH3's obligate binding partner in the mismatch repair complex
• MLH1 (MutL homolog 1) - downstream component of the MMR pathway
• Huntingtin (HTT) - polyglutamine disease-causing protein
• Trinucleotide repeat expansion - fundamental mechanism in polyglutamine diseases
• DNA mismatch repair - canonical cellular pathway for DNA quality control